Abstract:Background:Depression is a serious psychiatric disorder that creates a major public health burden of disease and disability. It is quite widespread;approximately 16% of individuals in the United States have suffered from clinical depression during their lifetime. While antidepressants have been available for several decades,most of them are not totally effective. New approaches to clinically treating depression are thus needed,and the molecular and cellular mechanisms underlying the pathophysiology of depression could provide a new therapeutic target. Cyclin-dependent kinase 5 (Cdk5),is a proline-directed serine/threonine kinase that is highly active in the brain and is important for the development of the central nervous system. Cdk5 has been implicated in synaptic plasticity,which underlies learning and memory,as well as neuropsychiatric pathologies like depression and bipolar disorder. Recently,it also has been reported that inhibition of Cdk5 activity in the hippocampus facilitates extinction of learned contextual fear memory,suggesting that Cdk5 could be a potential target for treatment of emotional disorders. However,hippocampal Cdk5’s potential role in the development of depressive diseases has not been examined.Objectives:To investigate the possible roles that Cdk5/p35 might play in the development of depressive-like symptoms,using the chronic mild stress rat model. Methods:Two hundred and ninety-two male Sprague-Dawley rats (weighing 200-220 g at the start of the study) were individually housed under a constant temperature (23±s 2 degrees Celsius) and maintained on a 12 h light/dark cycle with free access to food and water. In order to examine the effects of Cdk5/p35 activity in hippocampus on depressive-like behavior,rats were subjected to the chronic mild stress procedure for 3 weeks. Subsequently,the depressive-like behaviors including sucrose preference,bodyweight increase and locomotor activity were examined;Cdk5 kinase activity was measured by an in vitro phosphorylation assay,and membrane and cytosolic p35 levels were detected by Western blot analysis. In order to investigate whether Cdk5 is functionally related to the depressive-like symptoms elicited by the CMS procedure,Buty,a Cdk5 inhibitor,was infused into DG,CA1 and CA3 subfield,respectively. Over the next 3 weeks,they received injections in DG,CA1 or CA3 on days 1,7,14 and 21,as detailed in a previous study. The control groups received intra-DG,CA1 or CA3 injection of saline containing 0.2% DMSO or different doses of Buty (25,50 and 100 ng). The chronic mild stress groups were given intra-DG,CA1 or CA3 injections of saline containing 0.2% DMSO and different doses of Buty (25,50 and 100 ng) during the 3 weeks of chronic mild stress. Each intracranial injection was administrated between 8.00-10.00 am,1 h prior to stress exposure to the stressor. The day after the last stress exposure,the sucrose preference test was performed and then the animals were decapitated. Subsequently,bilateral tissue punches from CA1,CA3 and DG (16 gauge) were obtained. Proteins were extracted for kinase activity measurement and Western blot assay. The subsequent experiment was designed to determine the role p35 translocation plays in the actions of antidepressants. Four groups of rats (n=8 per group) were used to examine effects of the antidepressant venlafaxine on DG p35 translocation using a 2×2 design with the between-subject factors of Group (Control or CMS) and Treatment (vehicle or venlafaxine). The other four groups of rats (n=8 per group) were used to examine the effects of the antidepressant mirtazapine on DG p35 translocation using a 2×2 design,with the between-subject factors Group (Control or CMS) and Treatment (vehicle or mirtazapine). Intraperitoneal drug or vehicle injections were performed for 21 consecutive days in both the control and CMS groups. The day after the last stress exposure,the sucrose preference test was performed and the animals were decapitated. Subsequently,bilateral DG tissue punches (16 gauge) were obtained. The cytoplasmic and membrane protein levels were measured by Western blot assay. Results:CMS increased hippocampal Cdk5 activity,which was accompanied by an upregulation of membrane p35,a Cdk5 activator,and a reduction of cytosolic p35 in the dentate gyrus (DG). Microinjection of a Cdk5 inhibitor,butyrolactone,in DG,but not in CA1 or CA3,reversed the depressive-like behaviors induced by CMS. A negative linear correlation was found between sucrose preference,bodyweight increase and the membrane p35 level in DG. Chronic treatment with antidepressants venlafaxine and mirtazapine,but not the antipsychotic aripiprazole,prevented the aberrant translocation of p35 induced by CMS in DG. Conclusion:Our results revealed that the development of depressive-like behavior was associated with increased Cdk5 activity through p35 translocation from the cytosol to the membrane in DG. These findings suggest that hippocampal Cdk5/p35 complex mediated the depressive-like behavior induced by CMS;thus,Cdk5 could be a novel target for therapeutic treatment of major depression.

Blockage of p75NTR ameliorates depressive-like behaviours of mice under chronic unpredictable mild stress

Roles of P75ntr, Long-Term Depression, and Cholinergic Transmission in Anxiety and Acute Stress Coping

Dl-3-n-butylphthalide prevents chronic restraint stress-induced depression-like behaviors and cognitive impairment via regulating CaMKII/CREB/BDNF signaling pathway in hippocampus

p75NTR Ectodomain Ameliorates Cognitive Deficits and Pathologies in a Rapid Eye Movement Sleep Deprivation Mice Model

Brain-derived neurotrophic factor in 5-HT neurons regulates susceptibility to depression-related behaviors induced by subchronic unpredictable stress

Therapeutic targeting of STING-TBK1-IRF3 signalling ameliorates chronic stress induced depression-like behaviours by modulating neuroinflammation and microglia phagocytosis

A TrkB cleavage fragment in hippocampus promotes Depressive-Like behavior in mice

Baicalin ameliorates chronic unpredictable mild stress-induced depression through the BDNF/ERK/CREB signaling pathway

DI-3-n-butylphthalide mitigates stress-induced cognitive deficits in mice through inhibition of NLRP3-Mediated neuroinflammation

18β-Glycyrrhetinic Acid Ameliorates Neuroinflammation Linked Depressive Behavior Instigated by Chronic Unpredictable Mild Stress via Triggering BDNF/TrkB Signaling Pathway in Rats

Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice after Inflammation.

Neuroprotective Efficacy of Different Levels of High-Frequency Repetitive Transcranial Magnetic Stimulation in Mice with CUMS-induced Depression: Involvement of the P11/bdnf/homer1a Signaling Pathway.

Phosphodiesterase 7 inhibitor reduces stress-induced behavioral and cytoarchitectural changes in C57BL/6J mice by activating the BDNF/TrkB pathway

Areca catechu L . ameliorates chronic unpredictable mild stress-induced depression behavior in rats by the promotion of the BDNF signaling pathway

The expression of ProBDNF and its high affinity receptor P75NTR in the neurons of emotion-related brain regions of post-stroke depression rats

Nervonic acid improves depression like behaviors and demyelination of medial prefrontal cortex in chronic restraint stress mice

Atractylenolide I improves behaviors in mice with depression-like phenotype by modulating neurotransmitter balance via 5-HT2A

CUMS induces depressive-like behaviors and cognition impairment by activating the ERS-NLRP3 signaling pathway in mice

NMDA receptor partial agonist GLYX-13 alleviates chronic stress-induced depression-like behavior through enhancement of AMPA receptor function in the periaqueductal gray

CYCLIN-DEPENDENT KINASE 5 IN THE DENTATE GYRUS MEDIATES DEPRESSIVE-LIKE BEHAVIOR IN RATS

Tenuifolin ameliorates chronic restraint stress‐induced cognitive impairment in C57BL / 6J mice